David A. Siegel Johnson & Johnson Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Johnson & Johnson stock. As of the latest transaction made, Two Sigma Advisers, LP holds 2,346,243 shares of JNJ stock, worth $468 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
2,346,243
Previous 419,043
459.91%
Holding current value
$468 Million
Previous $64 Million
579.67%
% of portfolio
0.93%
Previous 0.14%
Shares
33 transactions
Others Institutions Holding JNJ
# of Institutions
4,826Shares Held
1.74BCall Options Held
20.4MPut Options Held
17.2M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...